Gareth Smith

Gareth Smith

Company: ImaginAb

Job title: General Manager, Europe


The Goldilocks Criteria – Rationale for antibody fragments in radiopharmaceutical therapy. 12:00 pm

Radiopharmaceutical Therapy (RPT) is gaining significant research interest in recent years. Many of the agents focused on delivering RPT to date have focused on small molecules (including peptides) or intact antibodies. This talk will focus on the utility of antibody fragment technologies to deliver RPT Antibody fragments such as nanobodies, diabodies, and minibodies offer the…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.